View drug registration information details.


ItemsRegistration information
ID257
No257
Brand NamePONADX
IngredientsPONATINIB 45 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC PHASE, ACCELERATED PHASE OR BLAST PHASE CHRONIC MYELOID LEUKEMIA THAT IS RESISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBITOR THERAPY OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA THAT IS REISISTANT OR INTOLERANT TO PRIOR TYROSINE KINASE INHIBIOTR THERAPY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE TABLETS
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 L 1248/24
FDD Registration Date03-DEC-2024
Expiry Date02-DEC-2029

Back to drug list